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p62  was  upregulated  in  the optic  nerve  after  intravitreal  injection  of TNF.
Treatment  with  p62  siRNA  exerted  a partial  but  signiﬁcant  protective  effect.
Rapamycin  both  decreased  p62  levels  and  exerted  substantial  axonal  protection.
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a  b  s  t  r  a  c  t
p62,  which  is  also  called  sequestosome  1  (SQSTM1),  plays  a critical  role  in  neuronal  cell death.  How-
ever,  the  role  of p62 in  axonal  degeneration  remains  unclear.  We  evaluated  whether  the  modulation  of
p62 expression  may  affect  axonal  loss  in tumor  necrosis  factor  (TNF)-induced  optic  nerve  degeneration.
Immunoblot  analysis  showed  that  p62  was  upregulated  in the  optic  nerve  after  intravitreal  injection  of
TNF. Treatment  with  p62 small  interfering  RNA (siRNA)  exerted  a  partial  but  signiﬁcant  protective  effecteywords:
62
apamycin
utophagy
umor necrosis factor
ptic nerve
against  TNF-induced  axonal  loss.  Rapamycin  exerted  substantial  axonal  protection  after  TNF  injection.
We  found  that the  increase  in p62  was signiﬁcantly  inhibited  by p62 siRNA.  Treatment  with  rapamycin
also  signiﬁcantly  inhibited  increased  p62  protein  levels  induced  by  TNF.  These  results  suggest  that  the
upregulation  of  p62  may  be involved  in TNF-induced  axonal  degeneration  and  that  decreased  p62  levels
may  lead  to axonal  protection.
©  2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BY
license  (http://creativecommons.org/licenses/by/3.0/).. Introduction
Autophagy is involved in a cell-protective process and plays
 role in cell death [1]. p62, which is also called sequestosome 1
SQSTM1), plays central roles in the autophagy machinery in sev-
ral types of cells. The accumulation of p62 has been linked to
eurodegenerative disease [2–4]. A recent study has demonstrated
hat the overexpression of p62 promotes apoptosis with the activa-
ion of caspase-8, while knockdown of p62 reduces human glioma
ell death [5]. p62 is normally degraded by the lysosomal proteases
hrough the interaction with LC3-II, an autophagic marker [6]. In
∗ Corresponding author at: Department of Ophthalmology, St. Marianna Univer-
ity School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511,
apan. Tel.: +81 44 977 8111; fax: +81 44 976 7435.
E-mail address: kitaoka@marianna-u.ac.jp (Y. Kitaoka).
ttp://dx.doi.org/10.1016/j.neulet.2014.08.021
304-3940/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access addition, a previous study demonstrated that p62 was upregulated
in the compressed spinal cord and that the forced expression of p62
decreased the number of neuronal cells under hypoxic stress [7].
These ﬁndings imply that p62 plays a critical role in neuronal cell
death.
The optic nerve consists of axons of retinal ganglion cells (RGCs),
and transient increases in LC3-II are seen in RGCs after optic nerve
transection [8]. Autophagy was reported to play a cytoprotective
role in RGCs after traumatic injury [9]. In contrast, the inhibi-
tion of autophagy resulted in an attenuation of RGC death in a
hypertensive glaucoma model [10]. Thus, the role of autophagy in
axonal degeneration of RGCs remains to be examined. We  previ-
ously demonstrated that there was a substantial increase in p62
protein levels in optic nerve samples 1 week after intraocular pres-
sure (IOP) elevation in a rat hypertensive glaucoma model [11].
However, the role of p62 in axonal degeneration remains unclear.
We therefore attempted to determine whether the modulation of
article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Data are presented as mean ± SEM. Differences among groups
were analyzed using one-way ANOVA, followed by Scheffe’s
method or Mann–Whitney’s method. A probability value of less8 K. Kojima et al. / Neurosc
62 expression affects axonal loss in tumor necrosis factor (TNF)-
nduced optic nerve degeneration. TNF is involved in certain types
f glaucoma [12–17], and the TNF injection model may  be useful
n understanding the mechanism of axonal degeneration of RGCs
18].
. Materials and methods
.1. Animals
Experiments were performed on 50- to 55-day-old male Wistar
ats. All studies were conducted according to the Association for
esearch in Vision and Ophthalmology (ARVO) statement for the
se of Animals in Ophthalmic and Vision Research and were
pproved by the Ethics Committee of the Institute of Experimental
nimals of St. Marianna University Graduate School of Medicine.
he animals were housed in controlled conditions, with temper-
ture at 23 ± 1 ◦C, humidity at 55 ± 5%, and light from 06:00 to
8:00.
.2. Administration of TNF
Intravitreal injection of TNF (Sigma–Aldrich, St. Louis, MO,
SA) was performed as described previously [18,19]. Brieﬂy, rats
ere anesthetized with an intramuscular injection of a mixture
f ketamine–xylazine (10 and 4 mg/kg, respectively). A single 2-l
njection of 10 ng TNF in 0.01 M PBS, pH 7.40, was  administered
ntravitreally into the right eye of an animal under a microscope
o avoid lens injury. PBS alone was administered into the con-
ralateral left eye as a control. For p62 small interfering RNA
siRNA) treatment, 50 pmol of p62 siRNA (SQSTM1/p62 siRNA II
6399S, Cell Signaling Technology, Danvers, MA,  USA) in 0.01 M
BS was administered intravitreally simultaneously mixed with a
0-ng TNF injection. In the rapamycin treatment group, 2 nmol of
apamycin (LC Laboratories, Woburn, MA,  USA) in 95% dimethyl
ulfoxide (DMSO)/dH2O was administered intravitreally simulta-
eously mixed with a 10-ng TNF injection. A previous study used
 single 1-l  intravitreal injection of 100% DMSO as sham con-
rol in mice and showed no RGC death [20]. Therefore, our current
MSO amount (2-l intravitreal injection of 95% DMSO/dH2O) in
ats is likely to yield a similar ﬁnal concentration. The rats were
uthanized 1 or 2 weeks after the intravitreal injections with an
ntraperitoneal overdose of sodium pentobarbital, followed by enu-
leation of the eye.
.3. Immunoblot analysis
Twenty-four rats were used for immunoblot analysis as
escribed previously [21]. Brieﬂy, 1 week after intravitreal injec-
ion, optic nerves (4 mm in length starting immediately behind
he globe) were collected, homogenized, and then centrifuged
t 15,000 × g for 15 min  at 4 ◦C Two optic nerve specimens were
ooled into one sample. Protein concentrations were determined
sing the Bio-Rad Protein Assay kit (Bio-Rad, Hercules, CA, USA).
rotein samples (5 g per lane) were subjected to SDS-PAGE on
els (Bio-Rad) and transferred to PVDF membranes (Immobilon-P,
illipore, Billerica, MA,  USA). Membranes were blocked with
ris-buffered saline (TBS)–0.1% Tween-20 containing 5% skim
ilk. Membranes were ﬁrst reacted with anti-p62 antibody
1:200; Medical & Biological Laboratories Co., Nagoya, Japan) or
nti--actin antibody (1:500; Sigma–Aldrich) in TBS containing
% skim milk. Membranes were then sequentially exposed to
eroxidase-labeled anti-rabbit IgG antibody (Cappel, Solon, OH,
SA) or peroxidase-labeled anti-mouse IgG antibody (Cappel)
iluted 1:5000 in Tween-20 in TBS. Western blots were visualized
ith an ECL detection system (Amersham ECL Prime Westernetters 581 (2014) 37–41
Blotting Detection Reagents, GE Healthcare, Buckinghamshire,
UK).
2.4. Axon counting in optic nerves
Morphometric analysis of each optic nerve was  performed as
described previously with samples from 18 rats [18,19,21]. Eyes
were obtained from the animals 2 weeks after intravitreal injec-
tion. Four-millimeter segments of the optic nerves were obtained
starting 1 mm behind the globe. These segments of optic nerve
were ﬁxed by immersion in Karnovsky’s solution for 24 h at 4◦C,
processed, and embedded in acrylic resin. Cross sections (1 m
thick) were cut beginning 1 mm  from the globe and stained with
a solution of 1% paraphenylene–diamine (Sigma–Aldrich) in abso-
lute methanol. For each section, images at the center and at each
quadrant of the periphery (approximately 141.4 m from the cen-
ter) were acquired with a light microscope (BX51; Olympus, Tokyo,
JAPAN) with a 100× coupled digital camera (MP5Mc/OL; Olym-
pus) and associated QCapture Pro software (version 5.1, QImaging,
Surrey, Canada). The acquired images were quantiﬁed using Aph-
elion image processing software (version 3.2, ADCIS SA and AAI,
Inc., Hérouville Saint Clair, France). The number of axons was
determined in ﬁve distinct areas of 1446.5 m2 each (each quad-
rant of the periphery in addition to the center; total area of
7232.3 m2 per eye) from each eye. The number of axons per eye
was averaged and expressed as the number per square millimeter.
A minimum of ﬁve eyes per experimental condition was used for
analysis.
2.5. Statistical analysisFig. 1. p62 protein levels in optic nerves. Immunoblot data are normalized to -
actin levels in the same sample. (A) Immunoblotting for p62 1 week after intravitreal
injection. (B) Data are expressed as a percentage of control. Each column represents
mean ± SEM. n = 4 (eight optic nerves) per group. *p < 0.05.
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. Results
.1. Effects of TNF, p62 siRNA, and rapamycin on p62 protein
evels in optic nerves
Because we previously found that p62 was increased in optic
erve samples 1 week after IOP elevation [11], in the current study
e examined the changes in p62 protein levels in the optic nerve
fter intravitreal injection. We  previously found that axonal loss
tarted 1 week after TNF injection [18] and the molecular events
efore axon loss becomes obvious are important for clarifying
he mechanism of axonal degeneration. There was  a substantial
ncrease in p62 protein levels in the optic nerve samples 1 week
fter TNF injection (Fig. 1). This increase was signiﬁcantly inhibited
y p62 siRNA (Fig. 1). Treatment with rapamycin also signiﬁcantly
nhibited the increase in p62 protein levels induced by TNF (Fig. 1).
ig. 2. Inhibition of p62 prevented TNF-induced axon loss. Light microscopic ﬁndings 2
njection, or (D) 10 ng TNF + rapamycin injection. Scale bar = 10 m (A–D). (E) Effect of p62
ean  ± SEM; n = 5–8 per group. *p < 0.05; **p < 0.005.etters 581 (2014) 37–41 39
3.2. Effects of modulation of p62 expression on TNF-induced
axonal degeneration
Compared with PBS-treated eyes (Fig. 2A), we  conﬁrmed sub-
stantial degenerative changes in the axons 2 weeks after TNF
injection (Fig. 2B), which is consistent with the ﬁndings of our
previous studies [18,19,21]. p62 siRNA-treated eyes showed mod-
est attenuated effects with better-preserved nerve ﬁbers (Fig. 2C).
Consistent with the ﬁndings that rapamycin exerted axonal pro-
tection in the hypertensive glaucoma model [11], treatment with
rapamycin also showed substantial protective effects on axons
against TNF-induced optic nerve degeneration (Fig. 2D). Quan-
titative analysis conﬁrmed that axonal loss was 43% after TNF
injection compared with controls (Fig. 2E). Treatment with p62
siRNA exerted a partial (38.8% protection) but signiﬁcant protective
effect against TNF-induced axonal loss (n = 5; p < 0.05 versus TNF
injection; Fig. 2E). Rapamycin-treated eyes showed 76.3% axonal
protection compared with eyes after TNF injection alone (n = 5;
p < 0.005 versus TNF injection; Fig. 2E).
 weeks after (A) PBS injection, (B) 10 ng TNF injection, (C) 10 ng TNF + p62 siRNA
 siRNA or rapamycin on axon numbers in the optic nerve. Each column represents
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. Discussion
The mammalian target of rapamycin (mTOR) activity was  sup-
ressed and new protein synthesis was impaired in axotomized
GCs, which may  contribute to the failure to regenerate [22]. Since
apamycin is an inhibitor of mTOR, it does not seem beneﬁcial for
xonal regeneration. However, a recent study has shown that mTOR
ctivity is not generally required for neuroprotection or switching
ature neurons into an active regenerative state in adult RGCs [23].
n the present study, rapamycin, an autophagy inducer, exerted a
ubstantial protective effect against axonal loss after TNF injection.
his ﬁnding is consistent with our previous results demonstrat-
ng that rapamycin exerted a signiﬁcant protective effect against
xonal loss after IOP elevation [11] and with those of another
tudy demonstrating that decreased Brn-3a-immunopositive RGCs
n ﬂat-mounted retinas after optic nerve transection were sig-
iﬁcantly increased by rapamycin [9]. Thus, it is possible that
apamycin can exert protective effects against several distinct optic
erve injury models, although a discrepancy was found between
europrotection and axonal regeneration [24].
In the present study, there was increase in p62 in the optic nerve
fter TNF injection. It was demonstrated that under pathological
onditions, there is a constitutively high level of p62, thereby lead-
ng to the accumulation of damaged mitochondria and subsequent
eactive oxygen species production [25]. We  cannot exclude the
ossibility that TNF-induced oxidative stress itself could upregulate
62, since a previous report demonstrated that lipopolysaccha-
ide mediated transcriptional up-regulation of p62 in RAW cells
26]. It was also demonstrated that the accumulation of p62 after
utophagy inhibition caused a delay in the clearance of short-
ived ubiquitin–proteasome system-speciﬁc substrates, like p53,
hich may  mediate toxicity [27]. Since p62 accumulates when
utophagy is inhibited, and decreased levels can be observed when
utophagy is induced, p62 may  be used as a marker of autophagy
ux [28]. Another aspect is that the level of p62 may  be dependent
n the balance of incoming, which is the transcriptional regulation
n response to various stimuli, and outgoing ﬂux, which is inﬂu-
nced by autophagic activity [29]. Although we could not determine
hether autophagic ﬂux was impaired in the optic nerve in this
tudy, the ﬁnding of an increase in p62 protein levels after TNF
njection is consistent with that of a previous study demonstrat-
ng that a sublethal dose of TNF signiﬁcantly increased the level
f p62 protein in PC12 cells [30]. That study suggested that TNF
cts not only as an inﬂammation mediator but also as a trigger of
utophagic impairment and neuronal damage [30]. It is reasonable
o speculate that p62 siRNA inhibited the neosynthesis of p62 pro-
ein in response to TNF injection. Another possibility is that p62
iRNA may  affect autophagy activity, because a recent study has
emonstrated that p62 siRNA activated autophagic machinery as
onﬁrmed by increases in lysosome-associated membrane protein
, LC3-II, and beclin 1 and by the formation of autophagosomes
31]. Therefore, it is possible that p62 siRNA exerts axonal protec-
ion with the involvement of autophagy machinery. However, the
nhibition of p62 alone exerted partial axonal protection. A recent
eport has suggested that p62 is a signaling node for multiple path-
ays and can potentially foster interaction between such pathways
n order to maintain cellular homeostasis [32], implicating that p62
as distinct roles depending on the physiological or pathological
onditions, or the status of proteasome activity. It was shown that
utophagy activation increased LC3-II levels and decreased p62 lev-
ls in several types of neuron [7,33]. In addition, we also found
hat rapamycin completely abolished the increase in p62 levels in
he optic nerve induced by TNF. The greater protective effect of
apamycin may  be because it not only inhibits p62 but also has
ther effects such as increasing in autophagic ﬂux. Nonetheless,
aking the results together, upregulation of p62 may  be involved
[etters 581 (2014) 37–41
in TNF-induced axonal degeneration and decreased p62 levels may
lead to axonal protection.
In conclusion, the present study showed that modulation of p62
levels in the optic nerve may  affect axonal degeneration. Clariﬁca-
tion of the detailed mechanism of the regulation of p62 levels may
lead to a new strategy for axonal protection in certain types of optic
neuropathy.
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